Ontology type: schema:MonetaryGrant
2004-2015
FUNDING AMOUNT2975056 USD
ABSTRACTPROJECT SUMMARY The overall aim of this project is to uncover the role of the mTOR (mammalian target of rapamycin) pathway and its relationship to p53 during normal and heart failure (HF) conditions. Myocardial mTOR activity, while increased in the early phases of pressure overload hypertrophy, eventually decreases when compensated hypertrophy switches to decompensation, ending in frank HF. We hypothesized therefore that mTOR and its downstream substrates are central in this process. For proving this, we therefore generated an inducible and cardiac-specific mouse model defective in mTOR (mTOR-cKO). We found that upon loss of mTOR, mice developed dilated heart phenotype that progressed rapidly to death. Markers of autophagy and apoptosis increased significantly; importantly, the tumor suppressor gene p53 significantly accumulated in the heart of mTOR KO mice; moreover, there was a remarkable myocardial accumulation of active 4E-BP1, a downstream member of the mTOR pathway which negatively controls mRNA translation in its dephosphorylated form and a major substrate of TORC-1, one of the two mTOR kinase multiprotein complexes. We found that acumulation of dephosphorylated 4E-BP1 is a feature of HF of diverse etiologies, and thus might represent a common mechanism underlying this state. We also found that deleting 4E-BP1 in mice determines a very significant improvement of cardiac function and survival in the context of cardiac mTOR KO. In other cellular systems, 4E-BPs were shown to regulate p53 protein levels. The specific aims of this project therefore are 1) to determine the relative role of apoptosis and autophagy in mTOR-defective HF and in particular the role of the key gene p53 and 2) determine the role of 4E-BPs in mTOR-dependent HF as well as the reciprocal control between 4E-BPs and p53. These tasks will be accomplished through cross-breeding experiments of mTOR-cKO mice with strains in which Atg5, a gene critical for autophagy, or Nix, a gene critical for apoptosis, are deleted. Also, the role of p53 will be assessed by crossing our model with mice with p53-floxed alleles. Gene expression and proteomic studies will be conducted with the aim to identify genes critical for mTOR-cKO HF. The involvement of 4E-BPs in regulating cardiac function as well as p53 levels will be addressed by crossing mTOR-cKO with double 4E-BP1/4E-BP2 KO mice and by studying the role of p53 in regulating 4E-BP1 expression. Results of our research will assess the relative and reciprocal role of mTOR/4E-BP1 and p53 in controlling cardiac function in the normal and diseased heart, opening the possibility to interfere with these molecules for therapeutic purposes. More... »
URLhttp://projectreporter.nih.gov/project_info_description.cfm?aid=8585080
http://scigraph.springernature.com/grant.2540161
DIMENSIONShttps://app.dimensions.ai/details/grant/grant.2540161
NIHR01HL078797
JSON-LD is the canonical representation for SciGraph data.
TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT
[
{
"@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json",
"about": [
{
"id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/2211",
"inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/",
"type": "DefinedTerm"
}
],
"amount": {
"currency": "USD",
"type": "MonetaryAmount",
"value": "2975056"
},
"description": "PROJECT SUMMARY The overall aim of this project is to uncover the role of the mTOR (mammalian target of rapamycin) pathway and its relationship to p53 during normal and heart failure (HF) conditions. Myocardial mTOR activity, while increased in the early phases of pressure overload hypertrophy, eventually decreases when compensated hypertrophy switches to decompensation, ending in frank HF. We hypothesized therefore that mTOR and its downstream substrates are central in this process. For proving this, we therefore generated an inducible and cardiac-specific mouse model defective in mTOR (mTOR-cKO). We found that upon loss of mTOR, mice developed dilated heart phenotype that progressed rapidly to death. Markers of autophagy and apoptosis increased significantly; importantly, the tumor suppressor gene p53 significantly accumulated in the heart of mTOR KO mice; moreover, there was a remarkable myocardial accumulation of active 4E-BP1, a downstream member of the mTOR pathway which negatively controls mRNA translation in its dephosphorylated form and a major substrate of TORC-1, one of the two mTOR kinase multiprotein complexes. We found that acumulation of dephosphorylated 4E-BP1 is a feature of HF of diverse etiologies, and thus might represent a common mechanism underlying this state. We also found that deleting 4E-BP1 in mice determines a very significant improvement of cardiac function and survival in the context of cardiac mTOR KO. In other cellular systems, 4E-BPs were shown to regulate p53 protein levels. The specific aims of this project therefore are 1) to determine the relative role of apoptosis and autophagy in mTOR-defective HF and in particular the role of the key gene p53 and 2) determine the role of 4E-BPs in mTOR-dependent HF as well as the reciprocal control between 4E-BPs and p53. These tasks will be accomplished through cross-breeding experiments of mTOR-cKO mice with strains in which Atg5, a gene critical for autophagy, or Nix, a gene critical for apoptosis, are deleted. Also, the role of p53 will be assessed by crossing our model with mice with p53-floxed alleles. Gene expression and proteomic studies will be conducted with the aim to identify genes critical for mTOR-cKO HF. The involvement of 4E-BPs in regulating cardiac function as well as p53 levels will be addressed by crossing mTOR-cKO with double 4E-BP1/4E-BP2 KO mice and by studying the role of p53 in regulating 4E-BP1 expression. Results of our research will assess the relative and reciprocal role of mTOR/4E-BP1 and p53 in controlling cardiac function in the normal and diseased heart, opening the possibility to interfere with these molecules for therapeutic purposes.",
"endDate": "2015-11-30T00:00:00Z",
"funder": {
"id": "https://www.grid.ac/institutes/grid.279885.9",
"type": "Organization"
},
"id": "sg:grant.2540161",
"identifier": [
{
"name": "dimensions_id",
"type": "PropertyValue",
"value": [
"2540161"
]
},
{
"name": "nih_id",
"type": "PropertyValue",
"value": [
"R01HL078797"
]
}
],
"inLanguage": [
"en"
],
"keywords": [
"mice",
"survival",
"task",
"Akt pathway",
"frank HF",
"heart failure",
"common mechanism",
"model",
"downstream substrates",
"tumor suppressor gene p53",
"mammalian target",
"autophagy",
"4E-BPs",
"cardiac-specific mouse model",
"rapamycin",
"heart",
"role",
"state",
"early phase",
"decompensation",
"pathway",
"mTOR KO mice",
"loss",
"dephosphorylated forms",
"Regulating Cardiac Function",
"mTOR-dependent HF",
"p53",
"research",
"aim",
"cross",
"pressure overload hypertrophy",
"specific aim",
"mTOR-cKO HF",
"alleles",
"acumulation",
"process",
"strains",
"possibility",
"mTOR",
"mTOR kinase multiprotein complexes",
"results",
"major substrate",
"4E-BP",
"BP2 KO mice",
"diverse etiologies",
"mTOR-cKO mice",
"apoptosis",
"cardiac function",
"gene expression",
"4E-BP1/4E",
"TORC-1",
"mTOR-cKO",
"molecules",
"4E-BP1 expression",
"conditions",
"downstream members",
"therapeutic purposes",
"Atg5",
"involvement",
"remarkable myocardial accumulation",
"4E-BP1",
"relationship",
"key gene p53",
"genes",
"mTOR/4E-BP1",
"markers",
"diseased heart",
"other cellular systems",
"Myocardial mTOR activity",
"mTOR pathway",
"experiments",
"significant improvement",
"project summaries",
"death",
"cardiac mTOR KO",
"reciprocal control",
"Nix",
"hypertrophy switches",
"mTOR-defective HF",
"reciprocal role",
"mRNA translation",
"context",
"p53 levels",
"overall aim",
"proteomic studies",
"features",
"p53 protein levels",
"relative roles",
"components",
"project",
"dilated heart phenotype"
],
"name": "Role of mTOR, a Component of the Akt Pathway, in Regulating Cardiac Function",
"recipient": [
{
"id": "https://www.grid.ac/institutes/grid.266100.3",
"type": "Organization"
},
{
"affiliation": {
"id": "https://www.grid.ac/institutes/grid.266100.3",
"name": "UNIVERSITY OF CALIFORNIA SAN DIEGO",
"type": "Organization"
},
"familyName": "KNOWLTON",
"givenName": "KIRK U",
"id": "sg:person.01321112106.55",
"type": "Person"
},
{
"member": "sg:person.01321112106.55",
"roleName": "PI",
"type": "Role"
}
],
"sameAs": [
"https://app.dimensions.ai/details/grant/grant.2540161"
],
"sdDataset": "grants",
"sdDatePublished": "2019-03-07T11:58",
"sdLicense": "https://scigraph.springernature.com/explorer/license/",
"sdPublisher": {
"name": "Springer Nature - SN SciGraph project",
"type": "Organization"
},
"sdSource": "s3://com.uberresearch.data.processor/core_data/20181219_192338/projects/base/nih_projects_10.xml.gz",
"startDate": "2004-12-01T00:00:00Z",
"type": "MonetaryGrant",
"url": "http://projectreporter.nih.gov/project_info_description.cfm?aid=8585080"
}
]
Download the RDF metadata as: json-ld nt turtle xml License info
JSON-LD is a popular format for linked data which is fully compatible with JSON.
curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/grant.2540161'
N-Triples is a line-based linked data format ideal for batch operations.
curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/grant.2540161'
Turtle is a human-readable linked data format.
curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/grant.2540161'
RDF/XML is a standard XML format for linked data.
curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/grant.2540161'
This table displays all metadata directly associated to this object as RDF triples.
135 TRIPLES
19 PREDICATES
113 URIs
105 LITERALS
5 BLANK NODES
Subject | Predicate | Object | |
---|---|---|---|
1 | sg:grant.2540161 | schema:about | anzsrc-for:2211 |
2 | ″ | schema:amount | Na9bba20b790f4ab5bd677cbc2d571ea1 |
3 | ″ | schema:description | PROJECT SUMMARY The overall aim of this project is to uncover the role of the mTOR (mammalian target of rapamycin) pathway and its relationship to p53 during normal and heart failure (HF) conditions. Myocardial mTOR activity, while increased in the early phases of pressure overload hypertrophy, eventually decreases when compensated hypertrophy switches to decompensation, ending in frank HF. We hypothesized therefore that mTOR and its downstream substrates are central in this process. For proving this, we therefore generated an inducible and cardiac-specific mouse model defective in mTOR (mTOR-cKO). We found that upon loss of mTOR, mice developed dilated heart phenotype that progressed rapidly to death. Markers of autophagy and apoptosis increased significantly; importantly, the tumor suppressor gene p53 significantly accumulated in the heart of mTOR KO mice; moreover, there was a remarkable myocardial accumulation of active 4E-BP1, a downstream member of the mTOR pathway which negatively controls mRNA translation in its dephosphorylated form and a major substrate of TORC-1, one of the two mTOR kinase multiprotein complexes. We found that acumulation of dephosphorylated 4E-BP1 is a feature of HF of diverse etiologies, and thus might represent a common mechanism underlying this state. We also found that deleting 4E-BP1 in mice determines a very significant improvement of cardiac function and survival in the context of cardiac mTOR KO. In other cellular systems, 4E-BPs were shown to regulate p53 protein levels. The specific aims of this project therefore are 1) to determine the relative role of apoptosis and autophagy in mTOR-defective HF and in particular the role of the key gene p53 and 2) determine the role of 4E-BPs in mTOR-dependent HF as well as the reciprocal control between 4E-BPs and p53. These tasks will be accomplished through cross-breeding experiments of mTOR-cKO mice with strains in which Atg5, a gene critical for autophagy, or Nix, a gene critical for apoptosis, are deleted. Also, the role of p53 will be assessed by crossing our model with mice with p53-floxed alleles. Gene expression and proteomic studies will be conducted with the aim to identify genes critical for mTOR-cKO HF. The involvement of 4E-BPs in regulating cardiac function as well as p53 levels will be addressed by crossing mTOR-cKO with double 4E-BP1/4E-BP2 KO mice and by studying the role of p53 in regulating 4E-BP1 expression. Results of our research will assess the relative and reciprocal role of mTOR/4E-BP1 and p53 in controlling cardiac function in the normal and diseased heart, opening the possibility to interfere with these molecules for therapeutic purposes. |
4 | ″ | schema:endDate | 2015-11-30T00:00:00Z |
5 | ″ | schema:funder | https://www.grid.ac/institutes/grid.279885.9 |
6 | ″ | schema:identifier | N580ffe78997c4f1396a6af5f04ab1227 |
7 | ″ | ″ | N988e8abbc3d0429d9543d5e039130d17 |
8 | ″ | schema:inLanguage | en |
9 | ″ | schema:keywords | 4E-BP |
10 | ″ | ″ | 4E-BP1 |
11 | ″ | ″ | 4E-BP1 expression |
12 | ″ | ″ | 4E-BP1/4E |
13 | ″ | ″ | 4E-BPs |
14 | ″ | ″ | Akt pathway |
15 | ″ | ″ | Atg5 |
16 | ″ | ″ | BP2 KO mice |
17 | ″ | ″ | Myocardial mTOR activity |
18 | ″ | ″ | Nix |
19 | ″ | ″ | Regulating Cardiac Function |
20 | ″ | ″ | TORC-1 |
21 | ″ | ″ | acumulation |
22 | ″ | ″ | aim |
23 | ″ | ″ | alleles |
24 | ″ | ″ | apoptosis |
25 | ″ | ″ | autophagy |
26 | ″ | ″ | cardiac function |
27 | ″ | ″ | cardiac mTOR KO |
28 | ″ | ″ | cardiac-specific mouse model |
29 | ″ | ″ | common mechanism |
30 | ″ | ″ | components |
31 | ″ | ″ | conditions |
32 | ″ | ″ | context |
33 | ″ | ″ | cross |
34 | ″ | ″ | death |
35 | ″ | ″ | decompensation |
36 | ″ | ″ | dephosphorylated forms |
37 | ″ | ″ | dilated heart phenotype |
38 | ″ | ″ | diseased heart |
39 | ″ | ″ | diverse etiologies |
40 | ″ | ″ | downstream members |
41 | ″ | ″ | downstream substrates |
42 | ″ | ″ | early phase |
43 | ″ | ″ | experiments |
44 | ″ | ″ | features |
45 | ″ | ″ | frank HF |
46 | ″ | ″ | gene expression |
47 | ″ | ″ | genes |
48 | ″ | ″ | heart |
49 | ″ | ″ | heart failure |
50 | ″ | ″ | hypertrophy switches |
51 | ″ | ″ | involvement |
52 | ″ | ″ | key gene p53 |
53 | ″ | ″ | loss |
54 | ″ | ″ | mRNA translation |
55 | ″ | ″ | mTOR |
56 | ″ | ″ | mTOR KO mice |
57 | ″ | ″ | mTOR kinase multiprotein complexes |
58 | ″ | ″ | mTOR pathway |
59 | ″ | ″ | mTOR-cKO |
60 | ″ | ″ | mTOR-cKO HF |
61 | ″ | ″ | mTOR-cKO mice |
62 | ″ | ″ | mTOR-defective HF |
63 | ″ | ″ | mTOR-dependent HF |
64 | ″ | ″ | mTOR/4E-BP1 |
65 | ″ | ″ | major substrate |
66 | ″ | ″ | mammalian target |
67 | ″ | ″ | markers |
68 | ″ | ″ | mice |
69 | ″ | ″ | model |
70 | ″ | ″ | molecules |
71 | ″ | ″ | other cellular systems |
72 | ″ | ″ | overall aim |
73 | ″ | ″ | p53 |
74 | ″ | ″ | p53 levels |
75 | ″ | ″ | p53 protein levels |
76 | ″ | ″ | pathway |
77 | ″ | ″ | possibility |
78 | ″ | ″ | pressure overload hypertrophy |
79 | ″ | ″ | process |
80 | ″ | ″ | project |
81 | ″ | ″ | project summaries |
82 | ″ | ″ | proteomic studies |
83 | ″ | ″ | rapamycin |
84 | ″ | ″ | reciprocal control |
85 | ″ | ″ | reciprocal role |
86 | ″ | ″ | relationship |
87 | ″ | ″ | relative roles |
88 | ″ | ″ | remarkable myocardial accumulation |
89 | ″ | ″ | research |
90 | ″ | ″ | results |
91 | ″ | ″ | role |
92 | ″ | ″ | significant improvement |
93 | ″ | ″ | specific aim |
94 | ″ | ″ | state |
95 | ″ | ″ | strains |
96 | ″ | ″ | survival |
97 | ″ | ″ | task |
98 | ″ | ″ | therapeutic purposes |
99 | ″ | ″ | tumor suppressor gene p53 |
100 | ″ | schema:name | Role of mTOR, a Component of the Akt Pathway, in Regulating Cardiac Function |
101 | ″ | schema:recipient | N62b2dae2a3224104b2bbd72f7abe4bae |
102 | ″ | ″ | sg:person.01321112106.55 |
103 | ″ | ″ | https://www.grid.ac/institutes/grid.266100.3 |
104 | ″ | schema:sameAs | https://app.dimensions.ai/details/grant/grant.2540161 |
105 | ″ | schema:sdDatePublished | 2019-03-07T11:58 |
106 | ″ | schema:sdLicense | https://scigraph.springernature.com/explorer/license/ |
107 | ″ | schema:sdPublisher | N2037deacdc1e453b8dfb09aeb353d1a5 |
108 | ″ | schema:startDate | 2004-12-01T00:00:00Z |
109 | ″ | schema:url | http://projectreporter.nih.gov/project_info_description.cfm?aid=8585080 |
110 | ″ | sgo:license | sg:explorer/license/ |
111 | ″ | sgo:sdDataset | grants |
112 | ″ | rdf:type | schema:MonetaryGrant |
113 | N2037deacdc1e453b8dfb09aeb353d1a5 | schema:name | Springer Nature - SN SciGraph project |
114 | ″ | rdf:type | schema:Organization |
115 | N580ffe78997c4f1396a6af5f04ab1227 | schema:name | dimensions_id |
116 | ″ | schema:value | 2540161 |
117 | ″ | rdf:type | schema:PropertyValue |
118 | N62b2dae2a3224104b2bbd72f7abe4bae | schema:member | sg:person.01321112106.55 |
119 | ″ | schema:roleName | PI |
120 | ″ | rdf:type | schema:Role |
121 | N988e8abbc3d0429d9543d5e039130d17 | schema:name | nih_id |
122 | ″ | schema:value | R01HL078797 |
123 | ″ | rdf:type | schema:PropertyValue |
124 | Na9bba20b790f4ab5bd677cbc2d571ea1 | schema:currency | USD |
125 | ″ | schema:value | 2975056 |
126 | ″ | rdf:type | schema:MonetaryAmount |
127 | anzsrc-for:2211 | schema:inDefinedTermSet | anzsrc-for: |
128 | ″ | rdf:type | schema:DefinedTerm |
129 | sg:person.01321112106.55 | schema:affiliation | https://www.grid.ac/institutes/grid.266100.3 |
130 | ″ | schema:familyName | KNOWLTON |
131 | ″ | schema:givenName | KIRK U |
132 | ″ | rdf:type | schema:Person |
133 | https://www.grid.ac/institutes/grid.266100.3 | schema:name | UNIVERSITY OF CALIFORNIA SAN DIEGO |
134 | ″ | rdf:type | schema:Organization |
135 | https://www.grid.ac/institutes/grid.279885.9 | ″ | schema:Organization |